NEUROPHET, Inc. (KOSDAQ:380550)
South Korea · Delayed Price · Currency is KRW 22,600
-350 (-1.53%)
Mar 20, 2026, 3:30 PM KST
NEUROPHET Market Cap
NEUROPHET has a market cap or net worth of 273.28 billion as of March 20, 2026.
Market Cap
273.28B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
22,600.00
Market Cap Chart
Since July 25, 2025, NEUROPHET's market cap has increased from 232.96B to 273.28B, an increase of 17.30%. That is a compound annual growth rate of 27.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 273.28B | 5.55% |
| Dec 30, 2025 | 258.91B | 11.14% |
| Jul 25, 2025 | 232.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.34T |
| Celltrion | 44.21T |
| ALTEOGEN | 19.25T |
| Sam Chun Dang Pharm. | 18.49T |
| Huons | 301.78B |
| JW Holdings | 296.48B |
| Korea United Pharm | 291.46B |
| HLB Therapeutics | 265.79B |